Anti-TMEFF2 Antibody represents a highly specialized monoclonal antibody specifically engineered to target the human TMEFF2 protein (Tomoregulin-1) with exceptional binding affinity. It effectively facilitates the measurable detection of TMEFF2-positive malignant cells across various preclinical experimental models to evaluate the delivery of cytotoxic payloads like Auristatin E (MMAE) during strictly monitored laboratory observation periods and molecular investigations to evaluate the disruption of prostate cancer progression.
Target:
Others
T9901A-1352
* VAT and and shipping costs not included. Errors and price changes excepted
